# Ramaco Resources, Inc.: financial statements, quarterly

METC · Nasdaq · CIK 1687187 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/metc.md) · [Financials](/companies/metc/financials.md) · [Filings](/companies/metc/filings.md) · [Insiders](/companies/metc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/metc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [187](/filings/0001558370-24-015069.md) | [203 d](/filings/0001104659-26-086668.md) | [173](/filings/0001558370-25-007370.md) | [155](/filings/0001558370-25-009974.md) | [167](/filings/0001213900-25-102891.md) | [171 d](/filings/0001104659-26-086668.md) | [135](/filings/0001104659-26-058647.md) | [153](/filings/0001104659-26-090902.md) | [121](/filings/0001213900-25-102891.md) | [128 d](/filings/0001104659-26-086668.md) | [122](/filings/0001104659-26-058647.md) | [145](/filings/0001104659-26-090902.md) |
| Cost of revenue | $m | [145](/filings/0001558370-24-015069.md) | [139 d](/filings/0001104659-26-086668.md) | [140](/filings/0001558370-25-007370.md) | [123](/filings/0001558370-25-009974.md) | [135](/filings/0001213900-25-102891.md) | [136 d](/filings/0001104659-26-086668.md) | [114](/filings/0001104659-26-058647.md) | [134](/filings/0001104659-26-090902.md) | [102](/filings/0001213900-25-102891.md) | [107 d](/filings/0001104659-26-086668.md) | [109](/filings/0001104659-26-058647.md) | [128](/filings/0001104659-26-090902.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [11.5](/filings/0001558370-24-015069.md) | [11.3 d](/filings/0001104659-26-086668.md) | [14.1](/filings/0001558370-25-007370.md) | [10.9](/filings/0001558370-25-009974.md) | [12.9](/filings/0001213900-25-102891.md) | [11.4 d](/filings/0001104659-26-086668.md) | [14.6](/filings/0001104659-26-058647.md) | [15.2](/filings/0001104659-26-090902.md) | [16.1](/filings/0001213900-25-102891.md) | [19.6 d](/filings/0001104659-26-086668.md) | [20.3](/filings/0001104659-26-058647.md) | [17.6](/filings/0001104659-26-090902.md) |
| Operating income | $m | [16.1](/filings/0001558370-24-015069.md) | [37.3 d](/filings/0001104659-26-086668.md) | [3.3](/filings/0001558370-25-007370.md) | [5.4](/filings/0001558370-25-009974.md) | [1.6](/filings/0001213900-25-102891.md) | [6.4 d](/filings/0001104659-26-086668.md) | [(12.0)](/filings/0001104659-26-058647.md) | [(13.8)](/filings/0001104659-26-090902.md) | [(14.5)](/filings/0001213900-25-102891.md) | [(15.6) d](/filings/0001104659-26-086668.md) | [(24.3)](/filings/0001104659-26-058647.md) | [(18.2)](/filings/0001104659-26-090902.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [1.7](/filings/0001213900-25-102891.md) | [(10.6) d](/filings/0001104659-26-086668.md) | [(2.2)](/filings/0001104659-26-058647.md) | [(2.8)](/filings/0001104659-26-090902.md) | [2.3](/filings/0001213900-25-102891.md) | [(15.1) d](/filings/0001104659-26-086668.md) | [(0.3)](/filings/0001104659-26-058647.md) | [(1.5)](/filings/0001104659-26-090902.md) |
| Income tax | $m | [5.5](/filings/0001558370-24-015069.md) | [8.8 d](/filings/0001104659-26-086668.md) | [0.5](/filings/0001558370-25-007370.md) | [0.9](/filings/0001558370-25-009974.md) | [0.1](/filings/0001213900-25-102891.md) | [2.2 d](/filings/0001104659-26-086668.md) | [(4.3)](/filings/0001104659-26-058647.md) | [(2.0)](/filings/0001104659-26-090902.md) | [(3.3)](/filings/0001213900-25-102891.md) | [(1.1) d](/filings/0001104659-26-086668.md) | [(5.8)](/filings/0001104659-26-058647.md) | [(4.2)](/filings/0001104659-26-090902.md) |
| Net income | $m | [19.5](/filings/0001558370-24-015069.md) | [30.0 d](/filings/0001104659-26-086668.md) | [2.0](/filings/0001213900-25-102891.md) | [5.5](/filings/0001213900-25-102891.md) | [(0.2)](/filings/0001213900-25-102891.md) | [3.9 d](/filings/0001104659-26-086668.md) | [(9.5)](/filings/0001104659-26-090902.md) | [(14.0)](/filings/0001104659-26-090902.md) | [(13.3)](/filings/0001213900-25-102891.md) | [(14.7) d](/filings/0001104659-26-086668.md) | [(18.3)](/filings/0001104659-26-090902.md) | [(15.4)](/filings/0001104659-26-090902.md) |
| Diluted EPS | $ per share | [0.40](/filings/0001558370-24-015069.md) | not reported | [0.00](/filings/0001558370-24-007598.md) | [0.08](/filings/0001558370-24-011591.md) | [(0.03)](/filings/0001558370-24-015069.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.41](/filings/0001558370-24-015069.md) | not reported | [0.00](/filings/0001558370-24-007598.md) | [0.08](/filings/0001558370-24-011591.md) | [(0.03)](/filings/0001558370-24-015069.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [42.9](/filings/0001558370-23-018430.md) | [42.0](/filings/0001558370-25-003144.md) | [30.5](/filings/0001558370-24-007598.md) | [27.6](/filings/0001558370-24-011591.md) | [22.9](/filings/0001558370-24-015069.md) | [33.0](/filings/0001104659-26-086668.md) | [43.5](/filings/0001558370-25-007370.md) | [28.1](/filings/0001558370-25-009974.md) | [194](/filings/0001213900-25-102891.md) | [440](/filings/0001104659-26-090902.md) | [355](/filings/0001104659-26-058647.md) | [283](/filings/0001104659-26-090902.md) |
| Current assets | $m | [169](/filings/0001558370-23-018430.md) | [190](/filings/0001558370-25-003144.md) | [183](/filings/0001558370-24-007598.md) | [161](/filings/0001558370-24-011591.md) | [147](/filings/0001558370-24-015069.md) | [168](/filings/0001104659-26-086668.md) | [164](/filings/0001558370-25-007370.md) | [155](/filings/0001558370-25-009974.md) | [329](/filings/0001213900-25-102891.md) | [598](/filings/0001104659-26-090902.md) | [543](/filings/0001104659-26-058647.md) | [461](/filings/0001104659-26-090902.md) |
| Total assets | $m | [647](/filings/0001558370-23-018430.md) | [666](/filings/0001558370-25-003144.md) | [674](/filings/0001558370-24-007598.md) | [659](/filings/0001558370-24-011591.md) | [645](/filings/0001558370-24-015069.md) | [675](/filings/0001104659-26-086668.md) | [686](/filings/0001558370-25-007370.md) | [675](/filings/0001558370-25-009974.md) | [850](/filings/0001213900-25-102891.md) | [1,141](/filings/0001104659-26-090902.md) | [1,092](/filings/0001104659-26-058647.md) | [1,025](/filings/0001104659-26-090902.md) |
| Current liabilities | $m | [143](/filings/0001558370-23-018430.md) | [170](/filings/0001558370-25-003144.md) | [148](/filings/0001558370-24-007598.md) | [121](/filings/0001558370-24-011591.md) | [109](/filings/0001558370-24-015069.md) | [122](/filings/0001104659-26-086668.md) | [124](/filings/0001558370-25-007370.md) | [114](/filings/0001558370-25-009974.md) | [111](/filings/0001213900-25-102891.md) | [110](/filings/0001104659-26-090902.md) | [111](/filings/0001104659-26-058647.md) | [109](/filings/0001104659-26-090902.md) |
| Total liabilities | $m | [294](/filings/0001558370-23-018430.md) | [296](/filings/0001558370-25-003144.md) | [302](/filings/0001558370-24-007598.md) | [293](/filings/0001558370-24-011591.md) | [284](/filings/0001558370-24-015069.md) | [312](/filings/0001104659-26-086668.md) | [330](/filings/0001558370-25-007370.md) | [327](/filings/0001558370-25-009974.md) | [323](/filings/0001213900-25-102891.md) | [657](/filings/0001104659-26-090902.md) | [655](/filings/0001104659-26-058647.md) | [649](/filings/0001104659-26-090902.md) |
| Long-term debt | $m | [34.2](/filings/0001558370-23-018430.md) | [0.3](/filings/0001558370-25-003144.md) | [24.7](/filings/0001558370-24-007598.md) | [42.2](/filings/0001558370-24-011591.md) | [43.1](/filings/0001558370-24-015069.md) | [0.1](/filings/0001213900-25-102891.md) | not reported | not reported | [116](/filings/0001213900-25-102891.md) | [468](/filings/0001104659-26-086668.md) | not reported | not reported |
| Current portion of debt | $m | [28.0](/filings/0001558370-23-018430.md) | [56.5](/filings/0001558370-25-003144.md) | [28.2](/filings/0001558370-24-007598.md) | [7.2](/filings/0001558370-24-011591.md) | [0.4](/filings/0001558370-24-015069.md) | [0.4](/filings/0001104659-26-086668.md) | [0.3](/filings/0001558370-25-007370.md) | [0.2](/filings/0001558370-25-009974.md) | [0.1](/filings/0001213900-25-102891.md) | [0.1](/filings/0001104659-26-090902.md) | [0.0](/filings/0001104659-26-058647.md) | not reported |
| Shareholders' equity | $m | [353](/filings/0001558370-24-015069.md) | [370](/filings/0001104659-26-086668.md) | [372](/filings/0001213900-25-102891.md) | [366](/filings/0001213900-25-102891.md) | [362](/filings/0001213900-25-102891.md) | [363](/filings/0001104659-26-090902.md) | [355](/filings/0001104659-26-090902.md) | [347](/filings/0001104659-26-090902.md) | [527](/filings/0001213900-25-102891.md) | [484](/filings/0001104659-26-090902.md) | [437](/filings/0001104659-26-090902.md) | [376](/filings/0001104659-26-090902.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [69.9 d](/filings/0001558370-24-015069.md) | [41.6 d](/filings/0001104659-26-086668.md) | [25.2](/filings/0001558370-25-007370.md) | [34.4 d](/filings/0001558370-25-009974.md) | [37.4 d](/filings/0001213900-25-102891.md) | [15.7 d](/filings/0001104659-26-086668.md) | [26.0](/filings/0001104659-26-058647.md) | [(4.3) d](/filings/0001104659-26-090902.md) | [(1.4) d](/filings/0001213900-25-102891.md) | [(18.4) d](/filings/0001104659-26-086668.md) | [(34.6)](/filings/0001104659-26-058647.md) | [12.2 d](/filings/0001104659-26-090902.md) |
| Capital expenditure | $m | [16.9 d](/filings/0001558370-23-018430.md) | [18.0 d](/filings/0001558370-24-003256.md) | [18.7](/filings/0001558370-24-007598.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [6.9 d](/filings/0001558370-23-018430.md) | [7.8 d](/filings/0001558370-25-003144.md) | [8.3](/filings/0001558370-25-007370.md) | [8.2 d](/filings/0001558370-24-011591.md) | [8.0 d](/filings/0001558370-24-015069.md) | [0.1 d](/filings/0001558370-25-003144.md) | [2.5](/filings/0001104659-26-058647.md) | [1.9 d](/filings/0001104659-26-090902.md) | [0.0 d](/filings/0001213900-25-102891.md) | [0.0 d](/filings/0001104659-26-086668.md) | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [11.9](/filings/0001104659-26-058647.md) | [54.0 d](/filings/0001104659-26-090902.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2019 (2019-09-30) | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | period not labelled (2023-06-20) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001558370-20-012402.md) | [0.0](/filings/0001558370-21-006928.md) | [0.0](/filings/0001558370-21-009805.md) | [0.0](/filings/0001558370-21-014093.md) | [0.0](/filings/0001558370-22-008756.md) | [0.0](/filings/0001558370-22-012874.md) | [0.0](/filings/0001558370-22-017155.md) | [0.0](/filings/0001558370-23-008818.md) | [45.1](/filings/0001558370-23-014253.md) | [44.5](/filings/0001558370-23-018430.md) | [44.7](/filings/0001558370-24-007598.md) | [0.0](/filings/0001558370-24-011591.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 44,414,085 at 2023-04-30, from the cover of the [10-Q filed 2023-05-09](/filings/0001558370-23-008818.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.